| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.099 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |